Osteomyelitis in Wound Care: When to Screen and What to Document

Osteomyelitis wound care screening is a clinical responsibility that changes the trajectory of wound management from routine care to a multidisciplinary problem requiring extended antibiotics, possible surgical intervention, and heightened documentation. In the mobile wound care setting, the clinician's role is not to definitively diagnose osteomyelitis. It is to screen for it, document the clinical suspicion, initiate the appropriate referral chain, and adjust the wound care plan accordingly.

The consequences of missing osteomyelitis are severe: continued wound management without addressing the underlying bone infection results in a wound that will not heal despite appropriate local care. The consequences of over-diagnosing it are also significant: unnecessary antibiotic courses, imaging studies, and surgical consultations that delay definitive wound management.

Which Wounds Need Osteomyelitis Wound Care Screening

Not every chronic wound requires osteomyelitis screening. Target screening efforts to wounds with established risk factors:

High-suspicion presentations:

Diabetic foot ulcers that probe to bone or have a depth >3 mm
Pressure injuries over bony prominences (sacrum, ischium, calcaneus, greater trochanter) with depth to or near bone
Any chronic wound with exposed bone
Wounds with sinus tracts that track toward bone
Non-healing wounds despite appropriate treatment for >6 weeks, especially over bony anatomy

Clinical indicators that raise suspicion:

Wound area >2 cm squared overlying bone
ESR (erythrocyte sedimentation rate) >70 mm/hr
Visible or palpable bone in the wound bed
Persistent purulent drainage despite appropriate wound care and topical antimicrobials
"Sausage toe" — diffuse swelling of an entire digit in a diabetic patient with an adjacent or overlying ulcer
Recurrent soft tissue infection at the same site despite adequate courses of antibiotics

The Probe-to-Bone Test

The probe-to-bone (PTB) test is the bedside screening tool for osteomyelitis in wound care. It is not a diagnostic test — it is a screening test that helps determine whether imaging and further workup are warranted.

Technique

Prepare the wound bed. Debride overlying slough or necrotic tissue to visualize the wound base. The test is meaningless if you are probing through non-viable tissue.
Use a sterile, blunt metal probe (a sterile metal wound probe or the blunt end of a surgical instrument). Do not use a cotton-tipped applicator — it lacks the rigidity to transmit tactile feedback.
Gently insert the probe into the deepest area of the wound, applying steady pressure without excessive force.
Assess what you feel. A positive test is contact with a hard, gritty surface — bone. The sensation is distinct from soft tissue, granulation, or tendon.
Document the finding. Record "probe-to-bone positive" or "probe-to-bone negative," the depth at which contact was made, and the location within the wound bed.

Interpreting the Result

The diagnostic accuracy of the PTB test depends on the clinical context:

In a high-risk population (diabetic foot ulcers with clinical infection): Positive predictive value is approximately 89%. A positive PTB in this population strongly suggests osteomyelitis and warrants imaging.
In a low-risk population (chronic wounds without infection): Positive predictive value drops. The test is more useful for ruling osteomyelitis out (negative predictive value >95% in low-prevalence settings) than for ruling it in.

Bottom line: A positive PTB test in a diabetic foot ulcer with clinical signs of infection is highly suspicious for osteomyelitis and should trigger imaging referral. A negative PTB test in a low-risk wound is reassuring and may not require further workup unless other clinical indicators are present.

Imaging Referral Criteria

When clinical screening raises suspicion for osteomyelitis, imaging confirms or excludes the diagnosis.

Imaging Hierarchy

Plain radiographs (X-ray): First-line imaging. Findings suggestive of osteomyelitis include cortical erosion, periosteal reaction, and focal osteopenia. However, plain films have low sensitivity (43-75%) in early osteomyelitis — bone changes may not be visible for 10-21 days after infection onset. A negative X-ray does not rule out osteomyelitis.

MRI: The gold standard for osteomyelitis detection. Sensitivity 82-100%, specificity 75-96%. MRI shows bone marrow edema, cortical disruption, and soft tissue extension that plain films miss. Order MRI when:

PTB test is positive
Plain films are negative but clinical suspicion remains high
Pre-surgical planning is needed to determine the extent of bone involvement

Nuclear medicine (bone scan, tagged WBC scan): Used when MRI is contraindicated (implanted hardware, pacemaker, severe claustrophobia) or when MRI is equivocal. Three-phase bone scan is sensitive but not specific — it cannot reliably distinguish osteomyelitis from other causes of increased bone turnover (fracture, Charcot arthropathy, post-surgical changes). Tagged WBC scan adds specificity but is not universally available.

What to Document on the Imaging Referral

Clinical findings that prompted the referral (PTB result, wound depth, duration, infection signs)
Which imaging modality is requested and why
Relevant history that affects imaging interpretation (prior surgery at the site, Charcot changes, hardware)
Labs ordered concurrently (ESR, CRP, CBC, procalcitonin if available)

Antibiotic Coordination

Mobile wound care practitioners typically do not prescribe antibiotics independently for osteomyelitis — this is managed by the PCP, infectious disease specialist, or orthopedic surgeon. However, the wound care clinician plays a critical coordinating role:

Culture guidance: If osteomyelitis is suspected and surgical debridement or biopsy is planned, bone culture is the gold standard for identifying the causative organism. Superficial wound cultures do not reliably predict bone pathogens. Communicate this to the surgical team — empiric antibiotic selection based on superficial swab results leads to inadequate coverage in approximately 30-40% of osteomyelitis cases.

Duration coordination: Osteomyelitis treatment typically requires 4-6 weeks of targeted antibiotic therapy (often IV followed by oral step-down). The wound care plan must account for this timeline:

Continue wound care visits during antibiotic therapy
Monitor for antibiotic-related complications (C. difficile, renal toxicity for vancomycin, peripheral neuropathy for prolonged fluoroquinolone use)
Reassess wound trajectory at antibiotic completion — if the wound is not progressing, reassess for treatment failure or retained infected bone

When to escalate: If the patient is on appropriate antibiotics and the wound is worsening (increasing erythema, new drainage, tissue breakdown at the wound margins), communicate findings to the prescribing provider immediately. Treatment failure may require antibiotic change, repeat imaging, or surgical intervention.

Documentation for Compliance

Osteomyelitis screening and coordination generate specific documentation requirements:

At every visit involving osteomyelitis suspicion:

PTB test result (positive/negative/not performed with rationale)
Wound depth measurement and structures visible or palpable
Infection assessment (NERDS/STONES criteria or equivalent)
Laboratory results if ordered (ESR, CRP, WBC, procalcitonin)
Imaging status — ordered, pending, results received (with findings summarized)
Antibiotic status — current regimen, duration to date, planned duration
Coordination notes — who was contacted, what was communicated, response received

Why this matters for billing: Wounds with confirmed or suspected osteomyelitis qualify for higher complexity E/M coding (medical decision-making involves moderate to high complexity when coordinating imaging, antibiotics, and specialist referrals). Ensure the documentation supports the complexity billed.

ICD-10 coding: When osteomyelitis is confirmed, add the appropriate M86 code to the wound diagnosis. Osteomyelitis coding is site-specific and must specify acute vs. chronic, which affects treatment planning and payer expectations for healing timelines.

Key Takeaways

Screen for osteomyelitis when a wound probes to bone, has failed to heal despite appropriate treatment, or overlies a bony prominence with persistent signs of infection
The probe-to-bone test is the initial screening tool -- a positive result (metal probe contacts bone through the wound) has high predictive value for osteomyelitis in DFU patients
Document the screening rationale, probe-to-bone result, imaging ordered, and referral decisions to support medical necessity for both the screening and any resulting treatment changes
MRI is the gold standard imaging modality -- plain radiographs miss early osteomyelitis but are useful as a baseline before ordering advanced imaging